BDX SEC Filings
SEC filings for BDX. Annual and quarterly reports, 8-K events,
Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 4Feld MichaelEVP, Chief Revenue Officer | Aug 27, 2026 | 0001628280-26-059269EDGAR |
| 4Feld MichaelEVP, Chief Revenue Officer | Aug 24, 2026 | 0001628280-26-058647EDGAR |
| 4Polen Thomas E JrChairman, CEO and President | Aug 14, 2026 | 0001628280-26-057166EDGAR |
| 4Goette RolandEVP and President, EMEA | Aug 12, 2026 | 0001628280-26-056366EDGAR |
| SC 13GSTATE STREET CORP | Aug 7, 2026 | 0000093751-26-000419EDGAR |
| SC 13GFirst Eagle Investment Management, LLC | Aug 6, 2026 | 0001325447-26-000023EDGAR |
| 8-K | Aug 6, 2026 | 0001628280-26-053790EDGAR |
| 10-Q | Aug 6, 2026 | 0000010795-26-000035EDGAR |
| 4Feld MichaelEVP, Chief Revenue Officer | Jul 28, 2026 | 0001628280-26-049989EDGAR |
| 8-K | Jul 22, 2026 | 0001628280-26-049103EDGAR |
| 4Muhsin BilalEVP & President Connected Care | Jul 6, 2026 | 0001628280-26-047193EDGAR |
| 4Feld MichaelEVP, Chief Revenue Officer | Jun 27, 2026 | 0001628280-26-045864EDGAR |
| 4Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Jun 25, 2026 | 0001628280-26-045374EDGAR |
| 4Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Jun 11, 2026 | 0001628280-26-042571EDGAR |
| 4Polen Thomas E JrChairman, CEO and President | Jun 3, 2026 | 0001628280-26-040095EDGAR |
| 4Menziuso PeterEVP and President, BDI | Jun 2, 2026 | 0001628280-26-039738EDGAR |
| 8-K | May 29, 2026 | 0001628280-26-039005EDGAR |
| 4Feld MichaelEVP, Chief Revenue Officer | May 27, 2026 | 0001628280-26-038382EDGAR |
| 8-K | May 20, 2026 | 0001140361-26-022270EDGAR |
| SC 13G/AamendedT. Rowe Price Investment Management, Inc. | May 15, 2026 | 0001897612-26-000461EDGAR |
| 8-K | May 12, 2026 | 0001140361-26-020828EDGAR |
| 4Roque VitorEVP & Chief Financial Officer | May 8, 2026 | 0001628280-26-032999EDGAR |
| 8-K/Aamended | May 7, 2026 | 0001628280-26-031642EDGAR |
| 10-Q | May 7, 2026 | 0000010795-26-000026EDGAR |
| 8-K | May 7, 2026 | 0001628280-26-031638EDGAR |
| SC 13GVanguard Capital Management | Apr 29, 2026 | 0002100119-26-000269EDGAR |
| SC 13GVanguard Portfolio Management | Apr 29, 2026 | 0002100121-26-000180EDGAR |
| 8-K | Apr 29, 2026 | 0000010795-26-000012EDGAR |
| 4Feld MichaelEVP, Chief Revenue Officer | Apr 28, 2026 | 0001628280-26-027731EDGAR |
| 8-K | Apr 9, 2026 | 0001628280-26-024472EDGAR |
| 4Neal Shana CarolEVP and Chief People Officer | Apr 6, 2026 | 0001628280-26-023944EDGAR |
| 8-K | Apr 2, 2026 | 0001628280-26-023185EDGAR |
| 4Feld MichaelEVP, Chief Revenue Officer | Mar 27, 2026 | 0001628280-26-021644EDGAR |
| SC 13G/AamendedVANGUARD GROUP INC | Mar 26, 2026 | 0000102909-26-000713EDGAR |
| 4Minnix LaneshaEVP and General Counsel | Mar 17, 2026 | 0001628280-26-018607EDGAR |
| 4Roque VitorInterim CFO | Mar 4, 2026 | 0001628280-26-014440EDGAR |
| 4Spikner Pamela L.SVP Controller & CAO | Mar 4, 2026 | 0001628280-26-014438EDGAR |
| 4Feld MichaelEVP, Chief Revenue Officer | Feb 27, 2026 | 0001628280-26-012955EDGAR |
| 8-K | Feb 25, 2026 | 0001140361-26-006794EDGAR |
| 4SCOTT BERTRAM L | Feb 18, 2026 | 0001628280-26-009242EDGAR |
| 4BECTON DICKINSON & CO | Feb 11, 2026 | 0001193125-26-046606EDGAR |
| 8-K | Feb 10, 2026 | 0001140361-26-004601EDGAR |
| 10-Q | Feb 9, 2026 | 0000010795-26-000005EDGAR |
| 8-K | Feb 9, 2026 | 0001628280-26-006182EDGAR |
| 8-K | Feb 9, 2026 | 0001193125-26-042827EDGAR |
| 8-K | Feb 5, 2026 | 0001628280-26-005793EDGAR |
| 8-K | Feb 5, 2026 | 0001193125-26-039448EDGAR |
| SC 13G/AamendedVANGUARD GROUP INC | Jan 30, 2026 | 0000102909-26-000132EDGAR |
| 8-K | Jan 30, 2026 | 0001628280-26-004393EDGAR |
| 4Henderson Jeffrey William | Jan 29, 2026 | 0001628280-26-004019EDGAR |
| 4ECKERT R ANDREW | Jan 29, 2026 | 0001628280-26-004017EDGAR |
| 4Byington Carrie L | Jan 29, 2026 | 0001628280-26-004015EDGAR |
| 4HAYES GREGORY | Jan 29, 2026 | 0001628280-26-004013EDGAR |
| 4Brown William M | Jan 29, 2026 | 0001628280-26-004010EDGAR |
| 4Huffines Robert Luther | Jan 29, 2026 | 0001628280-26-004008EDGAR |
| 4Jones Christopher Ian Montague | Jan 29, 2026 | 0001628280-26-004006EDGAR |
| 4RING TIMOTHY M | Jan 29, 2026 | 0001628280-26-004004EDGAR |
| 4SCOTT BERTRAM L | Jan 29, 2026 | 0001628280-26-004002EDGAR |
| 4Waldstreicher Joanne | Jan 29, 2026 | 0001628280-26-003999EDGAR |
| 4Wright Jacqueline | Jan 29, 2026 | 0001628280-26-003997EDGAR |
| 4Feld MichaelEVP, CRO & Pres. Life Sciences | Jan 28, 2026 | 0001628280-26-003734EDGAR |
| 4Spikner Pamela L.SVP Controller & CAO | Jan 23, 2026 | 0002012329-26-000002EDGAR |
| 4Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Jan 16, 2026 | 0001944816-26-000002EDGAR |
| 4Shan DavidEVP and Chief ISC Officer | Jan 6, 2026 | 0001963048-26-000002EDGAR |
| 8-K | Jan 6, 2026 | 0001193125-26-004659EDGAR |
| 4Feld MichaelEVP, CRO & Pres. Life Sciences | Dec 29, 2025 | 0001628280-25-058843EDGAR |
| 4Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Dec 18, 2025 | 0001628280-25-057774EDGAR |
| 4Feld MichaelEVP, CRO & Pres. Life Sciences | Dec 2, 2025 | 0001628280-25-054855EDGAR |
| 4Wright Jacqueline | Dec 2, 2025 | 0001628280-25-054703EDGAR |
| 4Huffines Robert Luther | Dec 2, 2025 | 0001628280-25-054700EDGAR |
| 4Mocherla Pavan KumarEVP & President, Greater Asia | Dec 1, 2025 | 0001628280-25-054380EDGAR |
| 4Shan DavidEVP and Chief ISC Officer | Dec 1, 2025 | 0001628280-25-054375EDGAR |
| 4Neal Shana CarolEVP and Chief People Officer | Dec 1, 2025 | 0001628280-25-054360EDGAR |
| 4Goette RolandEVP and President, EMEA | Dec 1, 2025 | 0001628280-25-054354EDGAR |
| 4Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Dec 1, 2025 | 0001628280-25-054351EDGAR |
| 4Feld MichaelEVP, CRO & Pres. Life Sciences | Dec 1, 2025 | 0001628280-25-054349EDGAR |
| 4DelOrefice ChristopherEVP & Chief Financial Officer | Dec 1, 2025 | 0001628280-25-054346EDGAR |
| 4Byrd RichardEVP & President Interventional | Dec 1, 2025 | 0001628280-25-054344EDGAR |
| 4Muhsin BilalEVP & President Connected Care | Dec 1, 2025 | 0001628280-25-054341EDGAR |
| 4Polen Thomas E JrChairman, CEO and President | Dec 1, 2025 | 0001628280-25-054339EDGAR |
| 4Spikner Pamela L.SVPController & Chief Acct Off | Dec 1, 2025 | 0001628280-25-054337EDGAR |
| 8-K/Aamended | Dec 1, 2025 | 0001628280-25-054447EDGAR |
| 10-K | Nov 25, 2025 | 0000010795-25-000099EDGAR |
| 8-K | Nov 17, 2025 | 0001628280-25-052625EDGAR |
| 4SCOTT BERTRAM L | Nov 7, 2025 | 0001628280-25-050735EDGAR |
| 8-K | Nov 6, 2025 | 0001628280-25-049835EDGAR |
| 4Feld MichaelEVP & President, Life Sciences | Oct 28, 2025 | 0001628280-25-046645EDGAR |
| 8-K | Oct 15, 2025 | 0001628280-25-045106EDGAR |
| 4Feld MichaelEVP & President, Life Sciences | Sep 29, 2025 | 0001628280-25-043134EDGAR |
| 8-K | Sep 18, 2025 | 0001140361-25-035307EDGAR |
| 4Fraser Claire | Sep 11, 2025 | 0001382031-25-000007EDGAR |
| 4DelOrefice ChristopherEVP & Chief Financial Officer | Sep 2, 2025 | 0000010795-25-000091EDGAR |
| 4Byrd RichardEVP & President Interventional | Sep 2, 2025 | 0000010795-25-000088EDGAR |
Never miss a BDX filing.
Get an email when BDX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.